CellRight Technologies LLC

Device Transactions Financing by device companies in the third quarter of 2017 totaled $2.38 billion, double Q2's $1.2 billion. ( See Exhibit 1. ) Debt again this quarter made up most of the aggregate

Regenerative medicine firm Tissue Regenix has named Steve Couldwell as its new CEO, following the departure of Anthony Odell, who led the group for over a decade. (Also see " Change At Helm As Tissue

Anthony Odell, who has been leading Tissue Regenix Group PLC for nearly a decade, is stepping down as CEO. His departure, announced Oct. 18, comes two months after he oversaw the closing of the re